Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Outcome of Childhood Acute Lymphoblastic Leukemia Treated Using the Thai National Protocols

  • Seksarn, Panya (Division of Hematology/Oncology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University) ;
  • Wiangnon, Surapon (Division of Pediatric Hematology/Oncology, Department of Pediatrics, Faculty of Medicine, Khon Kaen University) ;
  • Veerakul, Gavivann (Division of Pediatric Hematology/Oncology, Department of Pediatrics, Faculty of Medicine, Siriraj Hospital, Mahidol University) ;
  • Chotsampancharoen, Thirachit (Department of Pediatrics, Faculty of Medicine, Prince of Songkla University) ;
  • Kanjanapongkul, Somjai (Queen Sirikit National Institute of Child Health) ;
  • Chainansamit, Su-On (Department of Pediatrics, Khon Kaen Hospital)
  • Published : 2015.06.26
Download PDF
⟨ Previous Next ⟩

Abstract

Background: In recent decades, the prognosis for childhood leukemia has improved, especially for acute lymphoblastic leukemia (ALL). In Thailand, though, the survival rate for ALL is unimpressive. In 2006, standard national protocols for childhood leukemia treatment were implemented. We herein report the outcome of the ALL national protocols and explanations behind discrepancies in outcomes between institutions. Materials and Methods: Between March 2006 and February 2008, 486 children with ALL from 12 institutions were enrolled in the Thai national protocols. There were 3 different protocols based on specific criteria: one each for standard risk, high risk and Burkitt's ALL. We classified participating centers into 4 groups of institutions, namely: medical schools in Bangkok, provincial medical schools, hospitals in Bangkok and provincial hospitals. We also evaluated supportive care, laboratory facilities in participating centers, socioeconomics, and patient compliance. Overall and event-free survival were determined for each group using the Kaplan Meier method. Statistical differences were determined using the log-rank test. Previous outcomes of Thai childhood ALL treatment between 2003 and 2005 served as the historic control. Results: Five-year overall survival of ALL treated using the Thai national protocol was 67.2%; an improvement from the 63.7% of the 12-institute historical control (p-value=0.06). There were discrepancies in event-free survival of ALL between centers in Bangkok and up-country provinces (69.9% vs 51.2%, p-value <0.01). Socioeconomics and patient compliance were key elements in determining the outcome (65.5% vs 47.5%, 59.4% vs 42.9%) (p-value < 0.02). Conclusions: Implementation of standard national protocols for childhood leukemia in Thailand did not significantly improve the outcome of ALL. Factors leading to better outcomes included (a) improvement of treatment compliance (b) prevention of treatment abandonment and (c) financial support to the family.

Keywords

References

  1. Allemani C, Weir HK, Carreira H, et al (2015). Global surveillance of cancer survival 1995-2009: analysis of individual data for 25676887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet, 385, 977-1010. https://doi.org/10.1016/S0140-6736(14)62038-9
  2. Bhatia S, Landier W, Shangguan M, et al (2012). Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children's oncology group. J Clin Oncol, 30, 2094-101. https://doi.org/10.1200/JCO.2011.38.9924
  3. de Oliveira BM, Valadares MT, Silva MR, et al (2011). Compliance with a protocol for acute lymphoblastic leukemia in childhood. Rev Bras Hematol Hemoter, 33, 185-9. https://doi.org/10.5581/1516-8484.20110051
  4. de Oliveira BM, Viana MB, Zani CL, et al (2004). Clinical and laboratory evaluation of compliance in acute lymphoblastic leukemia. Arch Dis Child, 89, 785-8. https://doi.org/10.1136/adc.2003.030775
  5. Gupta S, Wilejto M, Pole JD, et al (2014). Low socioeconomic status is associated with worse survival in children with cancer: a systematic review. PLOS ONE, 9, 89482. https://doi.org/10.1371/journal.pone.0089482
  6. Gupta S, Yeh S, Martiniuk A, et al (2013). The magnitude and predictors of abandonment of therapy in paediatric acute leukaemia in middle-income countries: a systematic review and meta-analysis. Eur J Cancer, 49, 2555-64. https://doi.org/10.1016/j.ejca.2013.03.024
  7. Gutta G, Capocaccia R, Stiller C, et al (2005). Childhood cancer survival trends in Europe: A EUROCARE working group study. J Clin Oncol, 23, 3742-51. https://doi.org/10.1200/JCO.2005.00.554
  8. Gu LJ, Li J, Xue HL, et al (2008). Clinical outcome of children with newly diagnosed acute lymphoblastic leukemia treated in a single center in Shanghai, China. Leuk Lymphoma, 49, 488-94. https://doi.org/10.1080/10428190701784730
  9. Hazar V, Karasu GT, Uygun V, et al (2010). Childhood lymphoblastic leukemia in Turkey: factors influencing treatment and outcome: a single center experience. J Pedaitr Heamtol Oncol, 32, 317-22. https://doi.org/10.1097/MPH.0b013e3181ced271
  10. Hunger SP, Lu X, Devidas M, Camitta BM, et al (2012). Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. J Clin Oncol, 30, 1663-9. https://doi.org/10.1200/JCO.2011.37.8018
  11. Mostert S, Sitaresmi MN, Gundy CM, et al (2006). Influence of socioeconomic status on childhood acute lymphoblastic leukemia treatment in Indonesia. Pediatrics, 118, 1600-6. https://doi.org/10.1542/peds.2005-2700
  12. Mukda E, Pintaraks K, Komvilaisak P, et al (2011). Cytochemistry and multi-color flow cytometric immunophenotype for diagnosis of childhood acute leukemia. J Hematol Transfus Med, 21, 23-31.
  13. Pritchard M, Butow P, Stevens M, et al (2006). Understanding medication adherence in pediatric acute lymphoblastic leukemia: a review. J Pediatr Hematol Oncol, 28, 816-23. https://doi.org/10.1097/01.mph.0000243666.79303.45
  14. Seksarn P (2011). Outcome of childhood leukemia, ThaiPOG study. St Jude-VIVA forum in pediatric oncology, Singapore.
  15. Smith MA, Ries LAG, Gurney JG, Ross JA (1999). Retinoblastoma. In: Ries LAG, Smith MA, Gurney JG, Tamra T. Young JL, Bunin GR, editors. Cancer incidence and survival among children and adolescents: Unites States SEER Program 1975-1995. NIH Pub. No. 99-4649; 73-8.
  16. Stanulla M, Schrappe M. (2009). Treatment of childhood acute lymphoblastic leukemia. Semin Hematol, 46, 52-63. https://doi.org/10.1053/j.seminhematol.2008.09.007
  17. Tangcharoensathien V, Swasdiworn W, Jongudomsuk P, et al (2010). Universal coverage scheme in Thailand: equity outcomes and future agendas to meet challenges. Background paper, 43; World health report, World Health Organization.
  18. Thai Pediatric Oncology Group (2014). National Protocol for treatment of childhood cancer 2014. Bangkok, M Print Corporation.
  19. Tharnprisan P, Khiewyoo J, Sripraya P, Wiangnon S (2013). Relapse-free rate with childhood acute lymphoblastic leukemia treated under the Thai national protocol. Asian Pac J Cancer Prev, 14, 1127-30. https://doi.org/10.7314/APJCP.2013.14.2.1127
  20. Viana MB, Fernandes RA, de Oliveira BM, et al (2001). Nutritional and socio-economic status in the prognosis of childhood acute lymphoblastic leukemia. Haematologica, 86, 113-20.
  21. Wiangnon S, Jetsrisuparb A, Komvilaisak P, Suwanrungruang K (2014). Childhood cancer incidence and survival 1985-2009, Khon Kaen, Thailand. Asian Pac J Cancer Prev, 15, 7989-93. https://doi.org/10.7314/APJCP.2014.15.18.7989
  22. Wiangnon S, Veerakul G, Nuchprayoon I, et al (2011). Childhood cancer incidence and survival 2003-2005, Thailand: study from the Thai pediatric oncology Group. Asian Pac J Cancer Prev, 12, 2215-20.

Cited by

  1. High Expression of Lung Resistance Protein mRNA at Diagnosis Predicts Poor Early Response to Induction Chemotherapy in Childhood Acute Lymphoblastic Leukemia vol.16, pp.15, 2015, https://doi.org/10.7314/APJCP.2015.16.15.6663